Conmed (CNMD) Stock Buy Rating Kept at Needham; The Target Price is Set to $57.0; Fidelity National Information Servcs (FIS) Had 21 Bulls

October 12, 2017 - By Adrian Erickson

Among 5 analysts covering CONMED Corporation (NASDAQ:CNMD), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. CONMED Corporation has $60 highest and $44 lowest target. $50.75’s average target is -2.67% below currents $52.14 stock price. CONMED Corporation had 12 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Monday, October 5 by Leerink Swann. The firm has “Hold” rating by KeyBanc Capital Markets given on Wednesday, August 23. The firm earned “Buy” rating on Friday, November 18 by Needham. The stock of CONMED Corporation (NASDAQ:CNMD) has “Neutral” rating given on Thursday, August 27 by Piper Jaffray. Ladenburg Thalmann upgraded the shares of CNMD in report on Monday, October 12 to “Buy” rating. The rating was maintained by Needham on Thursday, August 31 with “Buy”. The rating was maintained by Needham on Thursday, July 27 with “Buy”. On Thursday, April 28 the stock rating was maintained by Needham with “Buy”. The company was downgraded on Wednesday, July 22 by Northland Capital. The firm has “Market Perform” rating given on Thursday, October 22 by Northland Capital.

Among 22 analysts covering Fidelity National Information Services (NYSE:FIS), 21 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Fidelity National Information Services had 45 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Fidelity National Information Servcs Inc (NYSE:FIS) earned “Neutral” rating by Goldman Sachs on Tuesday, March 28. The firm has “Outperform” rating by BMO Capital Markets given on Friday, January 6. The firm earned “Buy” rating on Wednesday, August 2 by Cowen & Co. The rating was maintained by Stephens on Thursday, August 3 with “Buy”. The stock of Fidelity National Information Servcs Inc (NYSE:FIS) earned “Outperform” rating by Credit Suisse on Wednesday, February 8. BMO Capital Markets maintained it with “Outperform” rating and $104 target in Thursday, August 3 report. The company was maintained on Wednesday, July 12 by RBC Capital Markets. As per Friday, April 1, the company rating was upgraded by Goldman Sachs. The rating was maintained by JP Morgan on Friday, August 14 with “Neutral”. The firm has “Overweight” rating by Barclays Capital given on Thursday, August 3. See Fidelity National Information Servcs Inc (NYSE:FIS) latest ratings:

10/10/2017 Broker: Robert W. Baird Rating: Outperform Old Target: $102 New Target: $108 Maintain
06/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $101.0 Maintain
06/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $102.0 Maintain
05/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $101.0 Maintain
03/08/2017 Broker: Barclays Capital Rating: Overweight Old Target: $94 New Target: $102 Maintain
02/08/2017 Broker: Credit Suisse Rating: Buy New Target: $96.0000 Upgrade
03/08/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $92 New Target: $104 Maintain
03/08/2017 Broker: Stephens Rating: Buy New Target: $101.0000 Maintain
02/08/2017 Broker: Cowen & Co Rating: Buy New Target: $97.0000 Maintain
12/07/2017 Broker: Credit Suisse Rating: Buy New Target: $89.0000

Since May 15, 2017, it had 0 buys, and 2 selling transactions for $205,900 activity. $153,661 worth of stock was sold by JONAS DANIEL on Monday, May 15. Kuyper Dirk sold $52,239 worth of stock or 1,000 shares.

Analysts await CONMED Corporation (NASDAQ:CNMD) to report earnings on October, 26. They expect $0.40 EPS, down 2.44% or $0.01 from last year’s $0.41 per share. CNMD’s profit will be $11.20 million for 32.59 P/E if the $0.40 EPS becomes a reality. After $0.41 actual EPS reported by CONMED Corporation for the previous quarter, Wall Street now forecasts -2.44% negative EPS growth.

CONMED Corporation is a medical technology company. The company has market cap of $1.46 billion. The Firm is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. It has a 93.61 P/E ratio. The Firm provides surgical devices and equipment for minimally invasive procedures.

About 910 shares traded. CONMED Corporation (NASDAQ:CNMD) has risen 27.59% since October 12, 2016 and is uptrending. It has outperformed by 10.89% the S&P500.

Investors sentiment decreased to 1.27 in 2017 Q2. Its down 0.06, from 1.33 in 2017Q1. It dropped, as 14 investors sold CONMED Corporation shares while 41 reduced holdings. 23 funds opened positions while 47 raised stakes. 26.82 million shares or 1.35% less from 27.19 million shares in 2017Q1 were reported. Geode Capital Mngmt Limited Liability Company has 0% invested in CONMED Corporation (NASDAQ:CNMD) for 224,258 shares. Champlain Investment Ptnrs Limited Liability Corp, a Us-based fund reported 1.75 million shares. California State Teachers Retirement Systems, California-based fund reported 48,630 shares. Citigroup invested in 181 shares. Northern has invested 0.01% in CONMED Corporation (NASDAQ:CNMD). Employees Retirement Systems Of Ohio reported 2,022 shares. Vanguard invested 0.01% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Bessemer Group invested in 0.01% or 34,706 shares. Moreover, State Teachers Retirement System has 0.01% invested in CONMED Corporation (NASDAQ:CNMD). Metropolitan Life Ins owns 19,426 shares or 0.01% of their US portfolio. Blackrock invested 0.01% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Creative Planning owns 235 shares. State Of Wisconsin Inv Board reported 127,562 shares. Martingale Asset Management Lp owns 82,308 shares for 0.06% of their portfolio. Lord Abbett Lc owns 270,430 shares.

About 17,317 shares traded. Fidelity National Information Servcs Inc (NYSE:FIS) has risen 14.58% since October 12, 2016 and is uptrending. It has underperformed by 2.12% the S&P500.

Investors sentiment decreased to 0.94 in Q2 2017. Its down 0.25, from 1.19 in 2017Q1. It is negative, as 42 investors sold Fidelity National Information Servcs Inc shares while 203 reduced holdings. 44 funds opened positions while 187 raised stakes. 281.10 million shares or 0.32% more from 280.19 million shares in 2017Q1 were reported. 2,415 were accumulated by Sun Life Financial Incorporated. Ig Investment Limited owns 737,467 shares for 0.33% of their portfolio. 66,699 were reported by Mastrapasqua Asset Mngmt. Moreover, Wealthtrust Fairport Lc has 0.55% invested in Fidelity National Information Servcs Inc (NYSE:FIS). Moreover, Amalgamated Comml Bank has 0.11% invested in Fidelity National Information Servcs Inc (NYSE:FIS). West Oak Capital Ltd Limited Liability Company owns 0% invested in Fidelity National Information Servcs Inc (NYSE:FIS) for 14,600 shares. Daiwa invested in 0.05% or 83,203 shares. Toronto Dominion Retail Bank reported 0.03% of its portfolio in Fidelity National Information Servcs Inc (NYSE:FIS). Moreover, Schmidt P J Management has 0.21% invested in Fidelity National Information Servcs Inc (NYSE:FIS) for 8,070 shares. Vantage Invest Advisors Limited Liability Company holds 0.01% or 454 shares. Yorktown Management Rech Communications stated it has 4,000 shares or 0.11% of all its holdings. Deltec Asset Llc owns 41,476 shares or 0.73% of their US portfolio. Dnb Asset As accumulated 33,972 shares. Montag A & Associate holds 7,000 shares or 0.07% of its portfolio. Frontier Mgmt Com Ltd Liability Corporation invested in 0% or 947 shares.

Since May 5, 2017, it had 0 insider purchases, and 4 selling transactions for $61.88 million activity. Shares for $20.77 million were sold by Norcross Gary. Woodall James W. had sold 70,667 shares worth $5.87 million. $22.08 million worth of Fidelity National Information Servcs Inc (NYSE:FIS) was sold by Oates Michael P on Friday, May 5.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>